NALP6 Antibody (920631) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # FAB9145JF669
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 669
Antibody Source
Monoclonal Mouse IgG2B Clone # 920631
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E.coli-derived recombinant human NLRP6/NALP6
Lys35-Arg193
Accession # P59044
Lys35-Arg193
Accession # P59044
Specificity
Detects human NLRP6/NALP6 in direct ELISAs.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2B
Applications for NALP6 Antibody (920631) [Janelia Fluor® 669]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
0
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: NLRP6/NALP6
Long Name
NLR Family, Pyrin Domain Containing 6
Alternate Names
AVR, CLR11.4, NALP6, NAVR, PAN3, PYPAF5
Gene Symbol
NLRP6
Additional NLRP6/NALP6 Products
Product Documents for NALP6 Antibody (920631) [Janelia Fluor® 669]
Product Specific Notices for NALP6 Antibody (920631) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...